In Ophthalmology science
Objective : To compare general ophthalmologists, retina specialists, and the EyeArt Artificial Intelligence (AI) system to the clinical reference standard for detecting more than mild diabetic retinopathy (mtmDR).
Design : Prospective, pivotal, multicenter trial conducted from April 2017 to May 2018.
Participants : Participants were aged ≥ 18 years who had diabetes mellitus and underwent dilated ophthalmoscopy. A total of 521 of 893 participants met these criteria and completed the study protocol.
Testing : Participants underwent 2-field fundus photography (macula centered, disc centered) for the EyeArt system, dilated ophthalmoscopy, and 4-widefield stereoscopic dilated fundus photography for reference standard grading.
Main Outcome Measures : For mtmDR detection, sensitivity and specificity of EyeArt gradings of 2-field, fundus photographs and ophthalmoscopy grading versus a rigorous clinical reference standard comprising Reading Center grading of 4-widefield stereoscopic dilated fundus photographs using the ETDRS severity scale. The AI system provided automatic eye-level results regarding mtmDR.
Results : Overall, 521 participants (999 eyes) at 10 centers underwent dilated ophthalmoscopy: 406 by nonretina and 115 by retina specialists. Reading Center graded 207 positive and 792 eyes negative for mtmDR. Of these 999 eyes, 26 eyes were ungradable by the EyeArt system, leaving 973 eyes with both EyeArt and Reading Center gradings. Retina specialists correctly identified 22 of 37 eyes as positive (sensitivity 59.5%) and 182 of 184 eyes as negative (specificity 98.9%) for mtmDR versus the EyeArt AI system that identified 36 of 37 as positive (sensitivity 97%) and 162 of 184 eyes as negative (specificity of 88%) for mtmDR. General ophthalmologists correctly identified 35 of 170 eyes as positive (sensitivity 20.6%) and 607 of 608 eyes as negative (specificity 99.8%) for mtmDR compared with the EyeArt AI system that identified 164 of 170 as positive (sensitivity 96.5%) and 525 of 608 eyes as negative (specificity 86%) for mtmDR.
Conclusions : The AI system had a higher sensitivity for detecting mtmDR than either general ophthalmologists or retina specialists compared with the clinical reference standard. It can potentially serve as a low-cost point-of-care diabetic retinopathy detection tool and help address the diabetic eye screening burden.
Lim Jennifer Irene, Regillo Carl D, Sadda SriniVas R, Ipp Eli, Bhaskaranand Malavika, Ramachandra Chaithanya, Solanki Kaushal
2023-Mar
AI, artificial Intelligence, Artificial intelligence, Diabetic retinopathy, Screening, CI, confidence interval, CSDME, clinically significant diabetic macular edema, DME, diabetic macular edema, DR, diabetic retinopathy, FDA, Food and Drug Administration, NPDR, nonproliferative diabetic retinopathy, PDR, proliferative diabetic retinopathy, WFPRC, Wisconsin Fundus Photograph Reading Center, mtmDr, more than mild diabetic retinopathy, vtDR, vision-threatening diabetic retinopathy
